Edition:
United Kingdom

Stemline Therapeutics Inc (STML.OQ)

STML.OQ on NASDAQ Stock Exchange Capital Market

13.60USD
7:12pm GMT
Change (% chg)

$0.15 (+1.12%)
Prev Close
$13.45
Open
$13.40
Day's High
$13.65
Day's Low
$13.25
Volume
12,440
Avg. Vol
57,344
52-wk High
$16.15
52-wk Low
$5.50

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 0.30 -0.660
Mar '17 0.30 -0.668
FY 2016 Dec '16 0.30 -0.560
Sep '16 0.30 -0.557
Jun '16 0.24 -0.524
Mar '16 0.21 -0.511
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 2 0.00 0.00 0.00 --
Quarter Ending Jun-18 2 0.00 0.00 0.00 --
Year Ending Dec-18 4 18.10 32.50 0.00 17.03
Earnings (per share)
Quarter Ending Mar-18 4 -0.62 -0.56 -0.68 --
Quarter Ending Jun-18 4 -0.60 -0.56 -0.63 --
Year Ending Dec-18 4 -1.80 -1.23 -2.28 -1.42
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.75 32.90
P/E High - Last 5 Yrs. -- 302.25 46.03
P/E Low - Last 5 Yrs. -- 94.23 24.39
Beta -0.12 0.88 0.89
Price to Sales (TTM) 252.25 94.46 5.41
Price to Book (MRQ) 3.76 13.37 5.38
Price to Tangible Book (MRQ) 3.78 13.65 6.89
Price to Cash Flow (TTM) -- 72.91 23.43
% Owned Institutions 49.44 11.52 2.16

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.27 1.51
Dividend 5 Year Growth Rate -- 1.72 5.23
Payout Ratio(TTM) -- 16.23 43.58

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 26.38 401.35 9.01
Sales (TTM) vs TTM 1 Yr. Ago 40.26 70.94 5.44
Sales - 5 Yr. Growth Rate -- 33.11 10.34
EPS (MRQ) vs Qtr. 1 Yr. Ago -25.96 29.52 19.33
EPS (TTM) vs TTM 1 Yr. Ago -14.13 -- --
EPS - 5 Yr. Growth Rate -- 40.23 10.77
Capital Spending - 5 Yr. Growth Rate -- 40.36 15.26

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.77 2.18
Current Ratio (MRQ) 4.65 5.22 2.97
LT Debt to Equity (MRQ) 0.00 21.07 12.10
Total Debt to Equity (MRQ) 0.00 22.62 16.38
Interest Coverage (TTM) -- -102.11 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 41.23 54.86
Gross Margin - 5 Yr. Avg. -- 52.57 52.45
EBITD Margin (TTM) -4,219.92 -- --
EBITD - 5 Yr. Avg -6,446.46 -239.65 15.33
Operating Margin (TTM) -4,220.23 -519.48 7.74
Operating Margin - 5 Yr. Avg. -6,468.54 -256.84 10.79
Pre-Tax Margin (TTM) -4,171.16 -495.13 8.53
Pre-Tax Margin - 5 Yr. Avg. -6,417.04 -256.77 11.19
Net Profit Margin (TTM) -4,171.28 -496.63 4.84
Net Profit Margin - 5 Yr. Avg. -6,415.84 -259.99 7.50
Effective Tax Rate (TTM) -- 23.31 23.05
Effective Tax Rate - 5 Yr. Avg. -- 18.78 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 41,297 23,331,032 855,738,258
Net Income/Employee (TTM) -1,722,596 3,081,067 100,666,768
Receivable Turnover (TTM) 19.87 20.25 5.76
Inventory Turnover (TTM) -- 2.31 3.34
Asset Turnover (TTM) 0.01 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -56.70 0.10 10.97
Return on Assets - 5 Yr. Avg. -47.10 0.51 12.39
Return on Investment (TTM) -65.15 3.21 14.40
Return on Investment - 5 Yr. Avg. -52.69 3.64 16.20
Return on Equity (TTM) -65.34 4.54 16.09
Return on Equity - 5 Yr. Avg. -53.70 8.99 17.53
  1 Year 3 Year 5 Year
Sales % 59.19 144.78 --
EPS (TTM) % 0.13 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Stemline Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 54.70%
# of Holders: 115
Total Shares Held: 13,831,659
3 Mo. Net Change: 792,030
# New Positions: 2
# Closed Positions: 1
# Increased Positions: 5
# Reduced Positions: 5
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.